21-

That's a wrap on the 2021 Capital Conference!

Sincerest thanks to the almost 500 people who joined us for the Gala and the Capital Conference. In spite of it being just our second post-COVID event, it was a rousing success. Thanks to all 45 companies who pitched and to the over 50 VC firms who attended. For the first time in 7 years, all 3 finalists in the Lion's Den received deals! We are already looking forward to next year.

Conference Recap

From the Gala the night before, to the Keynote session with Mark Zumoff and Tracy Wolfson, to the Lion's Den, there was a lot to digest in 24 hours. Check out the Capital Conferecne Recap for photos, videos and media coverage from Technical.ly Philly and the Philadelphia Business Journal.

NAVIGATION

ABOUT PACTCAPCON 2021

Event Pricing

PACT Member $499
Non-Member $600
Investors FREE for QUALIFIED Investors
Entrepreneur Program $100
Gala Reception $299

Registrations will only be accepted by website, post-mail, or email via cjarvisj@philadelphiapact.com. No registration will be taken over the phone, and full payment must accompany registration.

WHY SHOULD I ATTEND THE CAPITAL CONFERENCE?

Networking

You will have many opportunities to meet, greet and develop new relationships. There are scheduled networking break sessions, one-on-one business meetings, an exclusive investor dinner and cocktail reception leading up to the closing Gala Reception.

Business Development

With influential business leaders, legends, movers and shakers in the emerging growth community, the opportunities to build and expand your business networks are as inevitable as they prove invaluable.

Company Presentations

View emerging business models in technology, healthcare, and early stage industry specific tracks. See the latest technologies and cutting-edge innovations as companies and CEOs tell their stories.

Video highlights

Check out our playlist of over 45 videos with highlights from past Capital Conference events to see why it’s the premier private equity, venture capital, and entrepreneurial conference in the Northeast.

Photo Highlights

Networking, Lion’s Den, Receptions, and more. Click the gallery below to see photos from this year’s Capital Conference and the Gala event at the National Constitution Center.

2021 Capital Conference

2021 AGENDA

WEDNESDAY, November 3, 2021

6:00 – 9:00 p.m.  

GALA RECEPTION 

National Constitution Center
525 Arch St, Philadelphia, PA 19106

Join us and celebrate the region’s entrepreneurial spirit as we kick-off the PACT Capital Conference 2021. 

Sponsored by: Grant Thornton, Troutman Pepper, Bridgebank

 

 

THURSDAY, November 4, 2021 

8:30 AM – 6:00 PM 

Philadelphia Marriott Downtown
1201 Market Street, Philadelphia, PA 19107

8:30 a.m.  – REGISTRATION OPENS 

Outside Salons E-F

9:00 – 9:30 am:   BREAKFAST – OPENING REMARKS  

Salons E-F

9:30 – 10:15 a.m:  FEATURED COMPANY PRESENTATIONS    

Hear presentations from more than 40 of the region’s most promising investment opportunities in three industry-focused tracks. 

EARLY STAGE
Salon B
Sponsored by  Morgan Lewis

HEALTHCARE
Salon C 
Sponsored by EY

TECHNOLOGY
Salon D
Sponsored by Fox Rothschild

10:15 – 10:45 am:  NETWORKING / BREAKS  

There will be many opportunities to seek out that company or investment opportunity in a casual or structured way during our strategically placed networking sessions.  

Sponsored by EisnerAmper

10:45 – 11:30 am:  PANEL SESSIONS  

EARLY STAGE
Salon B 
TOPIC: Industry VC Perspectives- What are VC’s seeing today 

PANELISTS 

  • Brian Duggan, President, ClearList 
  • Sylvester Mobley, Managing Partner, Plain Sight Capital and Founder & CEO, Coded by Kids 
  • Katie Moore, Managing Director, Relation Management, Hamilton Lane 

Moderated by:

  • Doc Parghi, Managing Partner, SRI Capital

Sponsored by Morgan Lewis

HEALTHCARE 
Salon C
TOPIC: Looking Beyond Traditional “Health” – The path toward treating the Whole Person and not just the disease. 

Join a panel of experts for a lively discussion around unifying physical and behavioral health evaluation and treatment.  Our panel will include representatives of Philadelphia health care leaders Independence Blue Cross and the University of Pennsylvania Health system, along with entrepreneurs at the forefront of this exciting trend to treat the “whole patient” and drive improved patient outcomes. 

PANELISTS

  • Ammon Kansupada, CEO, Quartet Health 
  • Marsha Stone, Founder and Chief Strategy Officer, BRC Healthcare 
  • Matthew Press, MD, MSC, University of Pennsylvania Health System 

Moderated by:
Rodrigo Cerda, Vice President Clinical Transformation, Independence Blue Cross  

Sponsored by: Independence Blue Cross

TECHNOLOGY
Salon D
TOPIC: How Enterprise America is Re-tooling its Approach to Innovation

Years ago, ‘Big Pharma’ began to rethink how it approached new product development and innovation.  Instead of remaining insular and relying solely on their own internal R&D efforts, leading pharma companies consciously began taking the view that they should leverage the (orders of magnitude greater) global development efforts undertaken by venture-backed biotech companies and universities and apply their finance, regulatory and distributions strengths.  Accordingly, pharma companies have strengthened their venture investing and Corporate Development efforts and are routinely building their businesses through these mechanisms.  This approach is increasingly being embraced by players in other industry sectors.  Today, energy, automotive, insurance and other industrial participants are adopting the ‘Big Pharma’ model.   

PANELISTS

  • Antonia Dean, Director of Pipeline Diversity, Comcast Corporation 
  • Steven Hafif, Founder and CEO, Cypris 
  • Jake Rosenfeld, Co-founder, Bonsai

Moderated by:

  • Rebecca Guzman, Associate, Duane Morris LLP 

Sponsored by: Duane Morris

11:45 a.m. – 1:00 pm:  LUNCHEON – Keynote Speaker – A Conversation with: 

  • Marc Zumoff, Retired Philadelphia 76ers Sports Broadcaster & Broadcast   Coach
  • Tracy Wolfsonfour-time Emmy nominated sports broadcaster, CBS Sports

Salon E-F 

1:15. – 2:00 pm: FEATURED COMPANY PRESENTATIONS

EARLY STAGE
Salon B 
Sponsored by Morgan Lewis

HEALTHCARE
Salon C
Sponsored by EY

TECHNOLOGY
Salon D
Sponsored by Fox Rothschild

2:00 – 2:30 pm:   NETWORKING / BREAKS

Sponsored by Eisner Amper

2:30 – 3:15 pm:   FEATURED COMPANY PRESENTATIONS

EARLY STAGE
Salon B 
Sponsored by Morgan Lewis

HEALTHCARE
Salon C
Sponsored by EY

TECHNOLOGY
Salon D
Sponsored by Fox Rothschild

3:15 – 4:00 pm:   CANNABIS PANEL

CANNABIS – Salon A

  • Matt Taylor, Partner, Permit Capital Advisors 
  • Justin Singer, CEO, Caliper Holdings
  • Leah Heise, Cannabis Consultant
  • Brook Hayes, Partner and COO, Emerald Park Capital
  • Michael Bronstein, Co-­founder and President, Bronstein & Weaver, Inc

Moderated by:

  • Roger Braunfeld, Partner, Royer Cooper Cohen Braunfeld LLC

Sponsored by Royer Cooper Cohen Braunfeld LLC

3:45 – 4:15 pm:   NETWORKING / BREAKS

Sponsored by EisnerAmper

4:15 – 5:30 pm:   THE LION’S DEN

Salons E – F

A panel of highly successful entrepreneurs will be presented with 3 investment opportunities from the best of the conference featured companies.  Investment decisions will be made LIVE. 

The Lions 

  • Robert Corrato, M.D., Founder & CEO, Versalus Health  
  • Mikal C. Harden Founder & Chief Friend Maker, Juno Capital 
  • Max Kanevsky, CEO, Pinnacle 21, Founder, OpenCSISC
  • Robert Keith, President, Nouveau Capital 
  • Mike Wells, Managing Director, Princeton Biopharma Capital Partners

Moderator
Marc R. Lederman – General Partner, NewSpring Capital 

Co-sponsored by Cozen O’Connor and RSM

4:15 – 6:00 pm:  CLOSING RECEPTION

Outside of Salons E-F

Join us as we conclude Capital Conference 2021 by mixing and mingling with your fellow conference attendees. 

Sponsored by EisnerAmper

TECHNOLOGY 
Salon D  

TOPIC: How Enterprise America is Re-tooling its Approach to Innovation 

Years ago, ‘Big Pharma’ began to rethink how it approached new product development and innovation.  Instead of remaining insular and relying solely on their own internal R&D efforts, leading pharmaceutical companies consciously began taking the view that they should leverage the (orders of magnitude greater) global development efforts undertaken by venture-backed biotech companies and universities and apply their finance, regulatory and distributions strengths.  Accordingly, pharmaceutical companies have strengthened their venture investing and Corporate Development efforts and are routinely building their businesses through these mechanisms.  This approach is increasingly being embraced by players in other industry sectors.  Today, energy, automotive, insurance and other industrial participants are adopting the ‘Big Pharma’ model.   

PANELISTS 

  • Antonia Dean, Director of Pipeline Diversity, Comcast Corporation 
  • Steven Hafif, Founder and CEO, Cypris 

Moderated by:
Rebecca Guzman, Associate, Duane Morris LLP 

Sponsored by: Duane Morris

 

2021 Executive Leadership

John E. Royer, Jr.

RCCB Law

Neil A. Cooper

RCCB Law

Dean Miller

President & CEO

Cheryl J. Johnson

Director of Capital Conference

Glen R. Bressner

Activate Venture Partners

Kapila Ratnam, Ph.D.

NewSpring Capital

Doc Parghi

SRI Capital

Michael S. Harrington

Fox Rothschild, LLC

Steering Committee

Jeffrey Bodle
Partner, Morgan Lewis

Patrick Boyle
Partner-in-Charge of Audit and Assurance in PA, EisnerAmper

Glen Bressner
Managing Partner, Activate Venture Partners
Industry Track Vice Chair – Technology Track

Dave Burkavage
Assurance Partner, EY

Chris Cantz
Director, Content Marketing/PR, PACT

Andrew Cherry
Partner, KPMG LLP

Richard Cohen
Partner, Duane Morris LLP

Neil A. Cooper
Executive Partner, RCCB Law
Co-Chairman, PACT Capital Conference 2021

Sean Denham
Office Managing Partner, Grant Thornton LLP

Paul Dougherty
CPA, Partner-in-Charge, Philadelphia, EisnerAmper

Sean Dowling

Principal, Osage Partners

Robert Fesnak
Partner, Management Consulting Leader, PA/NJ
RSM US LLP

Heidi Franklin
Events Manager, PACT

Rick Genzer

Director of Investments, and Information Technology
Ben Franklin Technology Partner

David Gitlin
Partner, RCCB Law

Ira C. Gubernick
Member, Cozen O’Connor

Andrew Hamilton
Partner, Morgan Lewis

Michael Harrington
Partner, Fox Rothschild

Cheryl Jarvis-Johnson
Director, PACT
Conference Director, Sponsorship, Content, Internal

Matthew Klinger
SVP-Market Manager, MidAtlantic/Southeast Regions, Bridge Bank

Marc Lederman
General Partner, NewSpring Capital

Timothy Levy
Partner, RCCB Law

Paul Marvel
Market Managing Partner, PA/Southern NJ Offices
RSM US LLP

Dave Maturo
Director, Business Development, Grant Thornton LLP

Chris Miller
Partner, Troutman Pepper

Dean Miller
President & CEO, PACT
Managing Director, PCOM Innovation Fund

Doc Parghi
Managing Partner, SRI Capital
Industry Track Vice Chair – Early Stage Track

Kapila Ratnam, Ph.D.
General Partner, NewSpring Capital
Industry Track Vice Chair – Healthcare Track

Matthew Reber
Partner, 1315 Capital

John E. Royer, Jr
Managing Partner
RCCB Law
Co-Chairman, PACT Capital Conference 2021

Bryan Snellman
Senior Manager, EY

Pamela Zimlin
Partner, RCCB Law

Sponsors

Conference Host

gt-logo

Gala Sponsors

Titanium Sponsors

Industry Track Vice-Chair Sponsors

Early Stage

Healthcare

Technology

Platinum Sponsors

Specialty Sponsors

Gold Sponsors

University of Pennsylvania

Silver Sponsors

AMETEK
Ben Franklin Technology Partners/SEP
G-Squared Partners, LLC
Osage Partners

Bronze Sponsors

Ballard Spahr
BioAdvance
ClearList
Gabriel Investments
GMS Surgent
ORS Partners

Investor Supporters

Juno Search
Robin Hood Ventures
Tech Council Ventures

Community Partners

Black Girl Ventures
Chamber of Commerce for Greater Philadelphia
Delaware Crossing Investor Group
Mid-Atlantic Diamond Ventures
Mid-Atlantic – Eurasia Business Council
New Jersey Technology Council
PA Angel Network

Featured Companies

Out of over 150 submissions, around 45-50 Entrepreneurial Companies are chosen to pitch their innovations live in front of investors, professional advisors and key decision makers at the Capital Conference. During pitching hours, featured companies receive direct feedback with hopes to take home funding, gain experience and make lasting business connections. Then, select companies are chosen to enter the Lion’s Den for a shot at on-site commitments from highly successful entrepreneurs turned investors. Over the past 6 years companies have raised $5m in the aggregate of funding.

Early Stage Selections

BettorFantasy
Cliquify
Empact
EmpathED
FLX Solutions
Fulton
Journal My Health by Chariot Solutions
Kith + Kin
Lil Mixins
LLuna
Lula, Inc.
MindStand
Naturaz
Stash
Sweft

Healthcare Selections

BioStream Technologies
Cogwear
DermaClip
ExpressCells
Group K Diagnostics
Hale Therapeutics
Linshom
MBF Therapeutics
Neoneur
NeuTigers
Ostiio
Pression
Synthis Therapeutics
Trace Orthopedics
Trova Health

Technology Selections

Agora World
Boostpoint
CareAlign
Epilogue Systems
Face2Face Health
GoCoach
GrowFlux
Keriton
Premium Choice
Reflexion
Rymedi
Space-Eyes
studio BE
TEAMology
Veracuity

Featured Company Application

Out of over 150 submissions, around 45-50 Entrepreneurial Companies are chosen to pitch their innovations live in front of investors, professional advisors and key decision makers at the Capital Conference. During pitching hours, featured companies receive direct feedback with hopes to take home funding, gain experience and make lasting business connections. Then, select companies are chosen to enter the Lion’s Den for a shot at on-site commitments from highly successful entrepreneurs turned investors. Over the past 6 years companies have raised $5m in the aggregate of funding.

Qualifications

  • Top emerging companies from the Technology, Healthcare, and Early Stage sectors
  • 12-14 companies per industry to present in the months to come
  • All stages of development

We accept company slide decks and an optional 5 minute demo video for the selection committee to review. To be considered for a presentation slot, companies should include FULL CONTACT INFORMATION. 

Application Criteria

  • Decks should be limited to 15 slides (including the cover)
  • The following information shall be included/addressed in the Investor Deck:
    • Summary Financial Data: 5 YR Summary Income Statement: (Revenue, Cost of Goods Sold, Gross Margin and EBITDA) for the 2 most completed years, the current year and the next 2 years.  For example, a calendar year company would present 2019, 2020, 2021, 2022 and 2022.  If the company had no operations in 2018 or 2019 put N/A in applicable year(s).
      • Please list application information in this format:
        2019 2020 2021 2022 2023

        • Rev
        • CGS
        • GM
        • EBITDA
        • (Numbers in ‘000’s)
    • Capital Raised to Date.  Investors – If capital has been raised by institutional investors please note by who.  If raised by angle investors or HNW individual you may just note as Angles or HNW (unless you wish to disclose)
    • Amount of Financing Sought and use of funds
      • Please list the firms with which the company has key professional relationships, specifically (if applicable): Accounting, Legal and Commercial Bank
      • Current Headcount
      • Location
      • Contact information for the CEO and, if applicable, senior financial member of the team (Controller, VP of Finance, CFO)
  • The Investor Deck should address the following:
    • Vision/Elevator Pitch
    • The problem/pain point the offer addresses
    • Market Opportunity
    • Your Solution: Product/Service description
    • Please include stage (prototype, beta, live in 10 client sites, etc.)
    • Revenue Model and Pricing
    • Marketing Plan
    • Team
    • Financial Projections (see additional details above)
    • Competitive Landscape